Pan-cancer analysis of TOP2A, in terms of association with the clinical prognosis and involved molecular mechanisms based on profiling data, is necessary to understand the tumorigenesis mechanisms and explore the potential diagnostic biomarkers and treatment targets in clinical practice. Here, TOP2A is linked to cancer.